IGF::OT::IGF SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL

IGF::OT::IGF 特殊研究/分析 - 化学/生物

• 批准号: 9154513
• 负责人: ROBERT GIANNINI
• 金额: $ 13.28万
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-06-30 至 2020-06-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9154513
• 关键词: Biological; Biological Assay; Chemicals; Clinical; Clinical Trials; Contractor; Cyclic GMP; Development; Drug usage; High Pressure Liquid Chromatography; Housing; Human; Label; Liquid substance; Methods; Pharmaceutical Preparations; Phase; Procedures; Product Labeling; Production; Reporting; Shipping; Ships; Testing; Validation; Vial device; analytical method; repository

This agent is being developed in support of ongoing Phase I/II clinical trials, therefore these supplies are needed to support the human clinical trials. In support of the GMP production of this agent, following tasks need to be carried out:

该药物正在开发中，以支持正在进行的I/II期临床试验，因此需要这些供应品来支持人体临床试验。为了支持本制剂的GMP生产，需要执行以下任务：